APTALIS PHARMA INC Cash and Cash Equivalents
APTALIS PHARMA INC had Cash and Cash Equivalents of $132.00 million as of 2011-12-31, per its 10-Q filed 2012-02-10.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2012-02-10
- 2011-12-31: Cash and Cash Equivalents, at Carrying Value $132.00M.
- 2011-09-30: Cash and Cash Equivalents, at Carrying Value $126.51M.
- 2011-06-30: Cash and Cash Equivalents, at Carrying Value $114.78M.
- 2010-12-31: Cash and Cash Equivalents, at Carrying Value $150.74M.
| Period end | Cash and Cash Equivalents, at Carrying Value |
|---|---|
| 2011-12-31 | $132.00M 10-Q · filed 2012-02-10 |
| 2011-09-30 | $126.51M 10-Q · filed 2012-02-10 |
| 2011-06-30 | $114.78M 10-Q · filed 2011-08-12 |
| 2010-12-31 | $150.74M 10-Q · filed 2012-02-10 |
| 2010-09-30 | $161.50M 10-Q · filed 2012-02-10 |
| 2010-06-30 | $163.78M 10-Q · filed 2011-08-12 |
| 2009-09-30 | $126.44M 10-K · filed 2011-12-20 |
| 2008-09-30 | $56.10M 10-K · filed 2011-12-20 |